Navigation Links
Controversial medication may decrease spasms for infants with epilepsy
Date:2/2/2009

Helsinki, Finland February 02, 2009 The antiepileptic drug vigabatrin (VGB) has been shown to be one of the best treatments against a special form of epilepsy in infants, called infantile spasm. However, its use has been limited in many countries because it has been shown to cause a permanent narrowing of visual fields in approximately 40 percent of adults who have been exposed at school age or later. A new study published in Epilepsia examined school-aged children who had been treated with VGB in infancy. The findings showed normal visual fields in 15 of the 16 children studied children.

While VGB is an effective drug for infantile spasms, there have been no previous reports on later visual field testing after treatment in infancy. This study used a form of peripheral vision testing, called kinetic perimetry, which is effective in detecting peripheral field defects typical of VGB toxicity, and produces more reliable results in children.

Vigabatrin treatment began at a mean age of 7.6 months, and the mean duration of therapy was 21 months, with a mean cumulative dose of 655 grams. Three of the children had been previously treated with another anti-epileptic drug (AED), five had received only hormonal treatment, and eight children had never been treated with any form of AED.

The findings show that the risk of permanent visual field defects caused by VGB may be lower for treatments in infants than in adults. Results showed that 15 children had normal visual fields and mild visual field loss was observed in one child who had been treated with VGB for 19 months and received a cumulative dose of 572 grams. This frequency is lower than previous observations using kinetic perimetry in older children or adults.

The cumulative VGB doses and treatment durations in the study were, on average, lower than in previous studies, which correspond to the much younger age and weight of the tested patients.

"Our results may
'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Controversial Chemical Lingers Longer in the Body: Study
2. Rochester study raises new questions about controversial plastics chemical
3. American Association for Homecare Criticizes Release of Controversial Medicare Bidding Rule in Final Hours of Bush Administration
4. George Will Column Misguided in Touting Competitive Bidding as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled
5. Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide
6. Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin
7. 132 Members of Congress Urge One-Year Delay in Controversial Medicare Bidding Program for Home Medical Equipment
8. Californians Against Assisted Suicide - Controversial Bill, AB 2747 Narrowly Passes Assembly
9. Controversial shoulder surgery for first-time dislocation proven effective long-term
10. Controversial theory of Alzheimers origin funded
11. Controversial New Report Details Successes and Challenges as the Microcredit Movement Escalates Its Battle With Poverty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Lab Oven Industry, 2009-2019 is a professional and ... Oven industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, production value, and market ...
(Date:8/30/2014)... 2014 Serving contented clients since inception, ... By Outsourcing is now offering discount for Labor ... gives emphasize on putting forward the best of web ... Their dedicated team of professionals and web developers and ... handle even the critical issues of web development and ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed ... request to sever four cases selected for one ... Order issued on August 18, 2014, U.S. District ... of West Virginia disagrees with Boston Scientific’s contention ...
(Date:8/30/2014)... Saturday 30 August 2014: Transvenous lead extraction (TLE) ... according to data from the European Lead Extraction ConTRolled ... ESC Congress 2014 by Dr Maria Grazia Bongiorni, chair ... "The number of cardiac implantable electronic devices (CIED) implant ... technology the number of complications has increased and leads ...
(Date:8/30/2014)... OK (PRWEB) August 30, 2014 In ... valuable, and increasingly difficult to get. Snoring and sleep ... sleep and breathing stops) robs people and their bed ... daily challenges. Up to 45% of the population snores ... have sleep apnea. Of these, only 10% have been ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... 2008 As part of,its ongoing efforts to ... Relief and Development (LIFE), is preparing to,distribute high ... 20,medical schools and teaching hospitals in Iraq., ... American,non-governmental organization based in Pittsburgh, Pennsylvania, and the,Iraqi ...
... Persons with periodontitis who also are infected with ... developing tongue cancer, new research conducted at the ... shown., Periodontitis is a chronic inflammatory disease that ... It has been associated with various systemic diseases, ...
... Mich., April 4, 2008 Terumo Cardiovascular,Systems (Terumo ... a patent,infringement complaint by Maquet Cardiovascular LLC. The ... Terumo Corporation, had infringed,on two patents related to ... System., (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ), ...
... April 4, 2008 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ... of its Hepatitis C program at the upcoming,Canaccord Adams ... 1:30,p.m. ET at the St. Regis Hotel in New ... the company presentation can be,accessed under "Calendar of Events" ...
... improve stability and balance in women over age 65, which ... of Temple Universitys Gait Study Center. , Dr. Jinsup Song ... College of Health Professions examined the gait and postural stability ... yoga program specifically designed for those over 65. They found ...
... read and the Internet links included in them opened, ... off! Recipients are more likely to access the information ... applies to important medical information sent to a large ... a study conducted at the Department of Clinical Pharmacology ...
Cached Medicine News:Health News:HPV, periodontitis work in tandem to increase risk of tongue cancer 2Health News:Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement 2Health News:Poses can prevent falls 2Health News:Poses can prevent falls 3Health News:E-mail design pays off 2
(Date:8/29/2014)... -- Research and Markets has announced the ... of Pharmaceutical Equipment Market in China, 2014-2018" report ... Trend Forecast of Pharmaceutical Equipment Market in ... pharmaceutical equipment industry in the aspects of ... business performance of domestic major enterprises, as well as ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO ... 2011. Total revenue was $2.4 million and $5.5 million ... $1.1 million and $2.5 million for the same periods in 2010. ... ended June 30, 2011, were $7.6 million and $15.0 million as ...
... Pharmaceutical Care Management Association (PCMA) President and CEO Mark ... new lawsuit by several drugstore lobbying groups to prevent ... "California could have sidestepped this litigation and ... by following Governor Andrew Cuomo,s (D-NY) example ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11PCMA: California Medicaid Could Save $2 Billion, Avoid Drugstore Litigation by Modernizing Medicaid Pharmacy 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: